Literature DB >> 22051997

Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery.

R C McLean1, S M Nazarian, T J Gluckman, S P Schulman, D R Thiemann, E P Shapiro, J V Conte, J B Thompson, I Shafique, K W McNicholas, T C Villines, K M Laws, J J Rade.   

Abstract

AIM: The aim of the present study was to investigate the relative importance of a wide array of patient demographic, procedural, anatomic and perioperative variables as potential risk factors for early saphenous vein graft (SVG) thrombosis after coronary artery bypass graft (CABG) surgery.
METHODS: The patency of 611 SVGs in 291 patients operated on at four different hospitals enrolled in the Reduction in Graft Occlusion Rates (RIGOR) study was assessed six months after CABG surgery by multidetector computed tomography coronary angiography or clinically-indicated coronary angiography. The odds of graft occlusion versus patency were analyzed using multilevel multivariate logistic regression with clustering on patient.
RESULTS: SVG failure within six months of CABG surgery was predominantly an all-or-none phenomenon with 126 (20.1%) SVGs totally occluded, 485 (77.3%) widely patent and only 16 (2.5%) containing high-grade stenoses. Target vessel diameter ≤ 1.5 mm (adjusted OR 2.37, P=0.003) and female gender (adjusted OR 2.46, P=0.01) were strongly associated with early SVG occlusion. In a subgroup analysis of 354 SVGs in which intraoperative graft blood flow was measured, lower mean flow was also significantly associated with SVG occlusion when analyzed as a continuous variable (adjusted OR 0.984, P=0.006) though not when analyzed dichotomously, <40 mL/min versus ≥ 40 mL/min (adjusted OR 1.86, P=0.08).
CONCLUSION: Small target vessel diameter, female gender and low mean graft blood flow are significant risk factors for SVG thrombosis within six months of CABG surgery in patients on postoperative aspirin therapy. This information may be useful in guiding revascularization strategies in selected patients.

Entities:  

Mesh:

Year:  2011        PMID: 22051997      PMCID: PMC4430084     

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  29 in total

1.  Transit-time flow measurement is essential in coronary artery bypass grafting.

Authors:  Derek K H Leong; Venkataraman Ashok; Arulkumaran Nishkantha; Yue Hong Shan; Eugene K W Sim
Journal:  Ann Thorac Surg       Date:  2005-03       Impact factor: 4.330

2.  Intraoperative coronary graft flow determination--does it have a prognostic value for midterm graft patency?

Authors:  S M Cetin; P Massoudy; M Thielmann; C Yildirim; A Schmermund; R Erbel; H Jakob
Journal:  Eur J Med Res       Date:  2006-07-31       Impact factor: 2.175

3.  Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.

Authors:  Abdul R Halabi; John H Alexander; Linda K Shaw; Todd J Lorenz; Lawrence Liao; David F Kong; Carmelo A Milano; Robert A Harrington; Peter K Smith
Journal:  Am J Cardiol       Date:  2005-09-06       Impact factor: 2.778

4.  Factors influencing patency of saphenous vein grafts.

Authors:  J A Roth; R A Cukingnan; B G Brown; E Gocka; J S Carey
Journal:  Ann Thorac Surg       Date:  1979-08       Impact factor: 4.330

5.  Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).

Authors:  G Cataldo; M Braga; N Pirotta; M Lavezzari; F Rovelli; E Marubini
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

Review 6.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

7.  Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999.

Authors:  Pallav J Shah; Ian Gordon; John Fuller; Siven Seevanayagam; Alex Rosalion; James Tatoulis; Jai S Raman; Brian F Buxton
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

8.  Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.

Authors:  Harold L Lazar; Stuart R Chipkin; Carmel A Fitzgerald; Yusheng Bao; Howard Cabral; Carl S Apstein
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

9.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.

Authors:  Anthony P Furnary; Guangqiang Gao; Gary L Grunkemeier; YingXing Wu; Kathryn J Zerr; Stephen O Bookin; H Storm Floten; Albert Starr
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

10.  Prospective angiographic assessment of factors affecting early patency of saphenous vein-coronary artery bypass grafts.

Authors:  M Higginbotham; D Hunt; J Stuckey; G Sloman
Journal:  Aust N Z J Med       Date:  1980-06
View more
  8 in total

1.  Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.

Authors:  M T Olson; T S Kickler; J A Lawson; R C McLean; J Jani; G A FitzGerald; J J Rade
Journal:  J Thromb Haemost       Date:  2012-12       Impact factor: 5.824

2.  Cigarette smoking is associated with high HIV viral load among adults presenting for antiretroviral therapy in Vietnam.

Authors:  Todd M Pollack; Hao T Duong; Thuy T Pham; Cuong D Do; Donn Colby
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

3.  Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long-Term Outcome After Cardiac Surgery.

Authors:  Nikolaos Kakouros; Tyler J Gluckman; John V Conte; Thomas S Kickler; Katherine Laws; Bruce A Barton; Jeffrey J Rade
Journal:  J Am Heart Assoc       Date:  2017-11-02       Impact factor: 5.501

4.  Endoscopic or No-Touch Vein Harvesting for CABG: What is Best for the Patient?

Authors:  Tomislav Kopjar; Stjepan Ivankovic; Melchior Luiz Lima; Bruno Botelho Pinheiro; Michael Richard Dashwood
Journal:  Braz J Cardiovasc Surg       Date:  2016 Nov-Dec

5.  Development of a risk score for early saphenous vein graft failure: An individual patient data meta-analysis.

Authors:  Alexios S Antonopoulos; Ayodele Odutayo; Evangelos K Oikonomou; Marialena Trivella; Mario Petrou; Gary S Collins; Charalambos Antoniades
Journal:  J Thorac Cardiovasc Surg       Date:  2019-08-26       Impact factor: 5.209

6.  Aspirin dosage for the prevention of graft occlusion in people undergoing coronary surgery: A systematic review and meta-analysis.

Authors:  Fares Alahdab; Ruba Zuhri Yafi; Abdelkader Chaar; Ali Alrstom; Muayad Alzuabi; Omar Alhalabi; Somar Hasan; Mahmoud Mallak; Mohamad Luay Jazayerli; Qusay Haydour; Mohamad Alkhouli; Wedad Alfarkh; Mohammad Hassan Murad
Journal:  Avicenna J Med       Date:  2020-10-13

7.  Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.

Authors:  Vichai Senthong; Xinmin S Li; Timothy Hudec; John Coughlin; Yuping Wu; Bruce Levison; Zeneng Wang; Stanley L Hazen; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2016-06-07       Impact factor: 24.094

8.  Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery.

Authors:  Nikolaos Kakouros; Susanna M Nazarian; Patrizia B Stadler; Thomas S Kickler; Jeffrey J Rade
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.